We will hear from our distinguished speaker, Prof. Louise Berben. The event will include a presentation followed by a Q&A session.
Abstract: Small molecule transformations, such as CO2 or N2 reduction, in biology and solar fuels chemistry require multi-electron and multi-proton reaction sequences. The goal of synthetically realizing these reaction types provides a rich landscape for exploring new ideas in the design, synthesis, and characterization of inorganic and organometallic molecules. This talk will explore the molecular space where conjugated organic molecules and metal-metal bonded clusters provide electronic structures with delocalized frontier molecular orbitals. Just like in heterogeneous materials, these molecules have low kinetic barriers for electron and proton transfer reaction chemistry that enable transformations such as low potential ET, concerted ET, PT pathways and fast PT. These processes can be characterized using the powerful characterization tools of molecular chemistry to obtain new insights into reaction mechanisms and electronic structures.
Prof. Louise Berben was born in Sydney, Australia. She received a Bachelor of Science degree with 1st class honors from The University of New South Wales in 2000, and in 2005 was awarded a Ph.D. from the University of California Berkeley for research undertaken with Professor Jeffrey Long.
In 2006 Louise began postdoctoral research with Professor Jonas Peters at the California Institute of Technology and in July 2007, moved with the Peters research group to the Massachusetts Institute of Technology. In July 2009, Louise joined the faculty at the University of California Davis where her research program focuses primarily on synthetic and physical inorganic chemistry.
This event is FREE and Open to All!
Are you fascinated by crystals and porous materials? If this spark your curiosity, please come and join our lunch presentation by Prof. Adam Matzger from University of Michigan, an expert on porous materials and crystallization. In this presentation, Prof. Matzger will guide you through a journey of synthetic and functionalization strategies of metal-organic frameworks (MOFs), as well as exploring the recent advances of MOFs in gas adsorption and their potential in drug encapsulation and delivery. The presentation will be followed by a Q&A.
Zoom link to be shared with attendees the day of the event.
Join CalACS and our global partners for a speed networking event with students and professionals within the chemical sciences. Our partners include professional societies like NOBCChE, CACS, ebAWIS and many more! This event is a part of a larger global women’s breakfast happening through IUPAC.
All are welcomed!
Online Zoom link will be sent to registered participants on the day of the event.
About the speaker
Dr. Jillian R. Sanzone received her B.A. from New York University in Chemistry. She went on to earn her Ph.D. in 2018 at New York University under the advisement of Professor K. A. Woerpel working on the development of new synthetic reactions involving strained cyclic alkenes. In 2018, she relocated to San Francisco and started working in the Discovery Chemistry group at Merck Research Laboratories in South San Francisco, CA. Her current work includes inventing new small molecule drugs for the treatment of metabolic diseases and designing novel synthetic methods to enable medicinal chemistry programs at Merck.
In this talk, Dr. Sanzone will highlight the new Merck Research Laboratories site in South San Francisco, CA. Merck is a global healthcare company headquartered in New Jersey focusing on oncology, vaccines, infectious diseases, COVID-19 treatments, and cardiometabolic diseases. The Merck discovery hub in South San Francisco was established in 2017 and has grown to over 200 employees in the newly designed 290,000 square foot research and office space. The South San Francisco site focuses on developing treatments for cardiometabolic diseases and oncology. The Discovery Chemistry group enables these goals by leveraging the strong chemistry and scientific expertise at Merck to focus on discovering better molecules faster across modalities and advancing the best molecules into the pipeline to deliver to patients.
10:30 – 11:00 a.m. Chatting
11:00 a.m. Talk and Discussion
RSVP by February 2, 2021.
For more information visit our website at www.calacs.org or email firstname.lastname@example.org.
Here is the link for reservations starting December 28, 2020.
Our Distinguished Panelist:
Margaret R. McLean, PhD
Associate Director, Markkula Center for Applied Ethics
Santa Clara University
Markkula Center for Applied Ethics Associate Director McLean lectures on ethics relating to health care, health care justice and equity, and biotechnology. She will discuss the ethics surrounding Covid-19 and resource scarcity, including ventilators and vaccines. The presentation will cover ethical justice related to hospital care and the challenges of the vaccine roll-out. The presentation will be followed by a Q&A.